The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer ; day:25 ; month:04 ; year:2022
South Asian journal of cancer ; (25.04.2022)
- Beteiligte Personen und Organisationen
-
Shetty, Omshree
Vengurlekar, Vaibhavi
Kapoor, Akhil
Kamble, Vishakha
Gurav, Mamta
Bhargava, Prabhat
Srinivas, Sujay
Ramaswamy, Anant
Ramadwar, Mukta
Saklani, Avanish P.
Desouza, Ashwin
Ostwal, Vikas
- DOI
-
10.1055/s-0041-1740244
- URN
-
urn:nbn:de:101:1-2022060912024386947573
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shetty, Omshree
- Vengurlekar, Vaibhavi
- Kapoor, Akhil
- Kamble, Vishakha
- Gurav, Mamta
- Bhargava, Prabhat
- Srinivas, Sujay
- Ramaswamy, Anant
- Ramadwar, Mukta
- Saklani, Avanish P.
- Desouza, Ashwin
- Ostwal, Vikas
Ähnliche Objekte (12)
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
PIK3CA-mutations in breast cancer
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
PIK3CA mutations in endocrine-resistant breast cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Ras and Ras mutations in cancer
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
PIK3CA-mutations in breast cancer
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
PIK3CA mutations in endocrine-resistant breast cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Ras and Ras mutations in cancer
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
PIK3CA-mutations in breast cancer
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
PIK3CA mutations in endocrine-resistant breast cancer
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Ras and Ras mutations in cancer
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia